SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients

Stopped the project was never initiated and no participants were enrolled, it was closed permanently

Conditions

• Melanoma
• Metastatic Melanoma

Interventions

• RADIATION: SAbR
• DRUG: Ipilimumab
• DRUG: Nivolumab

Sponsor

University of Texas Southwestern Medical Center